647 related articles for article (PubMed ID: 30170108)
1. Development of a magnetic nano-graphene oxide carrier for improved glioma-targeted drug delivery and imaging: In vitro and in vivo evaluations.
Shirvalilou S; Khoei S; Khoee S; Raoufi NJ; Karimi MR; Shakeri-Zadeh A
Chem Biol Interact; 2018 Nov; 295():97-108. PubMed ID: 30170108
[TBL] [Abstract][Full Text] [Related]
2. Enhancement radiation-induced apoptosis in C6 glioma tumor-bearing rats via pH-responsive magnetic graphene oxide nanocarrier.
Shirvalilou S; Khoei S; Khoee S; Mahdavi SR; Raoufi NJ; Motevalian M; Karimi MY
J Photochem Photobiol B; 2020 Apr; 205():111827. PubMed ID: 32120183
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the combined effect of NIR laser and ionizing radiation on cellular damages induced by IUdR-loaded PLGA-coated Nano-graphene oxide.
Kargar S; Khoei S; Khoee S; Shirvalilou S; Mahdavi SR
Photodiagnosis Photodyn Ther; 2018 Mar; 21():91-97. PubMed ID: 29155336
[TBL] [Abstract][Full Text] [Related]
4. Co-encapsulation of superparamagnetic nanoparticles and doxorubicin in PLGA nanocarriers: Development, characterization and in vitro antitumor efficacy in glioma cells.
Luque-Michel E; Sebastian V; Larrea A; Marquina C; Blanco-Prieto MJ
Eur J Pharm Biopharm; 2019 Dec; 145():65-75. PubMed ID: 31628997
[TBL] [Abstract][Full Text] [Related]
5. In vivo evaluation of the combination effect of near-infrared laser and 5-fluorouracil-loaded PLGA-coated magnetite nanographene oxide.
Mohammadi Gazestani A; Khoei S; Khoee S; Emamgholizadeh Minaei S; Motevalian M
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):25-33. PubMed ID: 29543075
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic Effect of 5-Fluorouracil-loaded Polymer-coated Magnetite Nanographene Oxide Combined with Radiofrequency.
Asadi L; Shirvalilou S; Khoee S; Khoei S
Anticancer Agents Med Chem; 2018; 18(8):1148-1155. PubMed ID: 29623854
[TBL] [Abstract][Full Text] [Related]
7. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy.
Mao J; Meng X; Zhao C; Yang Y; Liu G
Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310
[TBL] [Abstract][Full Text] [Related]
8. A superparamagnetic Fe3O4-loaded polymeric nanocarrier for targeted delivery of evodiamine with enhanced antitumor efficacy.
Lv Y; Ding G; Zhai J; Guo Y; Nie G; Xu L
Colloids Surf B Biointerfaces; 2013 Oct; 110():411-8. PubMed ID: 23759382
[TBL] [Abstract][Full Text] [Related]
9. Anti-proliferate and apoptosis triggering potential of methotrexate-transferrin conjugate encapsulated PLGA nanoparticles with enhanced cellular uptake by high-affinity folate receptors.
Parmar A; Jain A; Uppal S; Mehta SK; Kaur K; Singh B; Sandhir R; Sharma S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):704-719. PubMed ID: 29745729
[TBL] [Abstract][Full Text] [Related]
10. Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma.
Ling Y; Wei K; Zou F; Zhong S
Int J Pharm; 2012 Jul; 430(1-2):266-75. PubMed ID: 22486964
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterisation and in vitro and in vivo evaluation of CD44-targeted chondroitin sulphate-conjugated doxorubicin PLGA nanoparticles.
Liu P; Chen N; Yan L; Gao F; Ji D; Zhang S; Zhang L; Li Y; Xiao Y
Carbohydr Polym; 2019 Jun; 213():17-26. PubMed ID: 30879657
[TBL] [Abstract][Full Text] [Related]
12. Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells.
Mosafer J; Teymouri M; Abnous K; Tafaghodi M; Ramezani M
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():123-133. PubMed ID: 28024568
[TBL] [Abstract][Full Text] [Related]
13. Dual-Targeting Lactoferrin-Conjugated Polymerized Magnetic Polydiacetylene-Assembled Nanocarriers with Self-Responsive Fluorescence/Magnetic Resonance Imaging for In Vivo Brain Tumor Therapy.
Fang JH; Chiu TL; Huang WC; Lai YH; Hu SH; Chen YY; Chen SY
Adv Healthc Mater; 2016 Mar; 5(6):688-95. PubMed ID: 26820074
[TBL] [Abstract][Full Text] [Related]
14. Primary M1 macrophages as multifunctional carrier combined with PLGA nanoparticle delivering anticancer drug for efficient glioma therapy.
Pang L; Zhu Y; Qin J; Zhao W; Wang J
Drug Deliv; 2018 Nov; 25(1):1922-1931. PubMed ID: 30465444
[TBL] [Abstract][Full Text] [Related]
15. Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells.
Kim TH; Jeong YI; Jin SG; Pei J; Jung TY; Moon KS; Kim IY; Kang SS; Jung S
Int J Nanomedicine; 2011; 6():2621-31. PubMed ID: 22114493
[TBL] [Abstract][Full Text] [Related]
16. Fluorescent magnetic PEI-PLGA nanoparticles loaded with paclitaxel for concurrent cell imaging, enhanced apoptosis and autophagy in human brain cancer.
Wang X; Yang L; Zhang H; Tian B; Li R; Hou X; Wei F
Colloids Surf B Biointerfaces; 2018 Dec; 172():708-717. PubMed ID: 30245296
[TBL] [Abstract][Full Text] [Related]
17. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
[TBL] [Abstract][Full Text] [Related]
18. Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations.
Liu G; Shen H; Mao J; Zhang L; Jiang Z; Sun T; Lan Q; Zhang Z
ACS Appl Mater Interfaces; 2013 Aug; 5(15):6909-14. PubMed ID: 23883622
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate and Curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: In vitro and in vivo evaluation.
Vakilinezhad MA; Amini A; Dara T; Alipour S
Colloids Surf B Biointerfaces; 2019 Dec; 184():110515. PubMed ID: 31585308
[TBL] [Abstract][Full Text] [Related]
20. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin.
Cui YN; Xu QX; Davoodi P; Wang DP; Wang CH
Acta Pharmacol Sin; 2017 Jun; 38(6):943-953. PubMed ID: 28552909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]